CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome? Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction The year in cardiology: heart failure: The year in cardiology 2019 Heart Failure Outcomes With Volume-Guided Management

Clinical Trial21 (12), 1596-1604

JOURNAL:Eur J Heart Fail. Article Link

Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial

B Pieske, MJ Patel, VICTORIA Study Group et al. Keywords: cyclic guanosine monophosphate; HFrEF; soluble guanylate cyclase

FULL TEXT PDF